Trikafta 37.5 mg (Ivacaftor TABLET) 37.5 MG

TRIKAFTA 37.5 MG tablets contain ivacaftor, a medication used to treat certain genetic conditions. This oral medication is designed to help manage symptoms associated with specific mutations.

Strength

37.5 MG

Manufacturer / TM Owner

VERTEX PHARMACEUTICALS (CANADA) INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRIKAFTA 37.5 MG tablets are primarily used to treat cystic fibrosis in patients with specific genetic mutations. This medication works by improving the function of a protein that regulates chloride transport in cells. What is TRIKAFTA used for? It is often prescribed to help manage symptoms and improve lung function in individuals with cystic fibrosis.

Side Effects

Common effects of TRIKAFTA 37.5 MG tablets may include headaches, stomach pain, and dizziness. Some users may also experience changes in liver function, so regular monitoring is recommended. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

TRIKAFTA 37.5 MG tablets should be used with caution in patients with liver problems. It is important to follow the prescribed dosage and monitor liver function regularly. Avoid grapefruit and grapefruit juice, as they can interact with ivacaftor.

Avoid Interactions

TRIKAFTA 37.5 MG tablets may interact with certain medications, including some antibiotics and antifungals. Alcohol and other substances that affect liver function should be avoided. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

TRIKAFTA 37.5 MG tablets are used to treat cystic fibrosis in patients with specific genetic mutations.

TRIKAFTA 37.5 MG tablets are taken orally, typically with fat-containing food to enhance absorption.

Common side effects may include headaches, stomach pain, and dizziness.

It is generally advised to avoid alcohol while taking TRIKAFTA 37.5 MG tablets.

If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.